Pages that link to "Q26864729"
Jump to navigation
Jump to search
The following pages link to Tuberculosis drug discovery in the post-post-genomic era (Q26864729):
Displaying 50 items.
- Learning from the past for TB drug discovery in the future (Q27485405) (← links)
- New insights into TB physiology suggest untapped therapeutic opportunities (Q28388477) (← links)
- Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense (Q28551800) (← links)
- Emerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome (Q30236042) (← links)
- Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options (Q30459034) (← links)
- The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053. (Q30692645) (← links)
- Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections (Q33655568) (← links)
- Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery (Q33901126) (← links)
- Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13. (Q33902627) (← links)
- Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease (Q33995001) (← links)
- Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome (Q34374612) (← links)
- Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3. (Q34471179) (← links)
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. (Q34484243) (← links)
- Mycobacterium tuberculosis metabolism (Q35245286) (← links)
- Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG (Q35670107) (← links)
- A High Throughput Screening Assay for Anti-Mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Lysis (Q35670579) (← links)
- Genetic Approaches to Facilitate Antibacterial Drug Development (Q35795582) (← links)
- Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis (Q35859964) (← links)
- The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis (Q35877895) (← links)
- Natural products as mediators of disease. (Q36200942) (← links)
- Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology (Q36973195) (← links)
- Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor (Q37034701) (← links)
- Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis (Q37089655) (← links)
- Mycobacterium tuberculosis replicates within necrotic human macrophages (Q37700122) (← links)
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects (Q38199573) (← links)
- Future target-based drug discovery for tuberculosis? (Q38280137) (← links)
- The future for early-stage tuberculosis drug discovery (Q38358621) (← links)
- Clinical value of whole-genome sequencing of Mycobacterium tuberculosis (Q38567338) (← links)
- Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs (Q38778343) (← links)
- Inhibiting Mycobacterium tuberculosis within and without (Q38965421) (← links)
- Chemotherapy of leishmaniasis: present challenges (Q39011875) (← links)
- NR1D1 ameliorates Mycobacterium tuberculosis clearance through regulation of autophagy. (Q39961230) (← links)
- Identification of the anti-mycobacterial functional properties of piperidinol derivatives. (Q40333807) (← links)
- Dissecting host factors that regulate the early stages of tuberculosis infection (Q40565763) (← links)
- Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection (Q40673986) (← links)
- A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis (Q41529160) (← links)
- Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery (Q41927049) (← links)
- A genome-wide structure-based survey of nucleotide binding proteins in M. tuberculosis. (Q42083154) (← links)
- Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach. (Q42368535) (← links)
- Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies. (Q46532888) (← links)
- IFN-β: A Contentious Player in Host-Pathogen Interaction in Tuberculosis. (Q47274901) (← links)
- Hit Generation in TB Drug Discovery: From Genome to Granuloma (Q47702665) (← links)
- Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets. (Q52676415) (← links)
- RepTB: a gene ontology based drug repurposing approach for tuberculosis. (Q54203363) (← links)
- Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis? (Q55333929) (← links)
- Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1): challenging target for antitubercular drug discovery. (Q55437850) (← links)
- Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach (Q57093867) (← links)
- Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis (Q57291166) (← links)
- Exploitation of Mangrove Endophytic Fungi for Infectious Disease Drug Discovery (Q57478729) (← links)
- Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis (Q57656314) (← links)